Home R&D

R&D

Boehringer & Enara Bio forge cancer immunotherapy agreement
Featured

Boehringer & Enara Bio forge cancer immunotherapy agreement

Dominic Cuthbert -
0
CureVac & Bayer partner for COVID-19 vaccine candidate
Featured

CureVac & Bayer partner for COVID-19 vaccine candidate

Dominic Cuthbert -
0
Reach Separations enters purification alliance with NovAliX
Featured

Reach Separations enters purification alliance with NovAliX

Tess Egginton -
0
Exploratory research project to develop novel protein expression systems via cell reprogramming
Featured

Exploratory research project to develop novel protein expression systems via cell reprogramming

Tess Egginton -
0
First COVID patients enrolled in AM-Pharma’s Phase III trial
Featured

First COVID patients enrolled in AM-Pharma’s Phase III trial

Dominic Cuthbert -
0
Avacta enters license agreement with POINT Biopharma
Featured

Avacta enters license agreement with POINT Biopharma

Dominic Cuthbert -
0
Positive results for aTyr Pharma’s COVID-19 candidate
Featured

Positive results for aTyr Pharma’s COVID-19 candidate

Dominic Cuthbert -
0
COVAXX and Aurobindo Pharma enter COVID-19 vaccine partnership
Featured

COVAXX and Aurobindo Pharma enter COVID-19 vaccine partnership

Dominic Cuthbert -
0
Major study launches to better understand link between genetics & human disease
Featured

Major study launches to better understand link between genetics & human disease

Dominic Cuthbert -
0
Lilly & UnitedHealth Group to study neutralising antibody for COVID-19
Featured

Lilly & UnitedHealth Group to study neutralising antibody for COVID-19

Dominic Cuthbert -
0
123...179Page 1 of 179

© 2020 Part of the Business Link Magazine Group. Armstrong House, Armstrong Street, Grimsby,
North East Lincolnshire, DN31 2QE

About Us

Popular Category

Editor Picks